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Abstract Multiple protein kinase C (PKC) a species, identi¢ed
in an erythroleukaemia cell line, have been characterised in
terms of their molecular properties and intracellular distribu-
tion. PKCas localised in the detergent-soluble cell fraction
have an Mr of 76 kDa (a-76) and contain Thr538 or pThr538
in the kinase activation loop. In contrast, PKCas localised in the
Golgi complex have an Mr of 85 kDa (a-85) and, although
unphosphorylated at Thr538, are catalytically active. Strikingly,
only a-76 species which are unphosphorylated at Thr538 can
undergo autocatalytic conversion to a-85. Moreover, a
Thr538CAla PKCa mutant is constitutively localised in the
Golgi complex, con¢rming that changes in the phosphorylation
state of this residue play a pivotal role in the overall control of
catalytic properties and localisation of this kinase.
- 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Protein kinase C (PKC) a is a member of the novel PKC
isozyme subfamily which is activated by lipid cofactors [1].
The highest expression levels of this kinase have been detected
in skeletal muscle and haematopoietic cells [2], but an increas-
ing number of cell types, including endothelial, melanoma and
mast cells, hepatocytes and nerve cell lines have also been
shown to express PKCa [3^8]. This kinase has distinct func-
tions according to the cell type. In non-haematopoietic cells it
is involved in the mechanisms underlying actin polymerisation
and cell motility [3,9]. Conversely, in mature T cells PKCa
plays a non-redundant role in cell activation and proliferation
processes [10]. The involvement of PKCa in murine erythro-
leukaemia (MEL) cell cycle regulation has also been hypothe-
sised, as this kinase is recruited to the mitotic spindle during
cell division and is down-regulated in growth-arrested cells
[11]. In any case, activation of PKCa functions is preceded
by its translocation from a soluble compartment to speci¢c
cell microdomains as lipid rafts, cytoskeletal structures or a
supramolecular activation complex. These relocations of
PKCa involve interaction of this kinase isozyme with mem-
brane lipids or with guanine nucleotide exchange factors; they
also involve autophosphorylation as well as transphosphory-
lation events that are catalysed by protein kinases activated in
di¡erent conditions [12^14]. Among the transphosphorylation
sites, Thr538 in the activation loop of PKCa has been indi-
cated as a target for PDK1 activity, and the presence of
pThr538 has been proposed as a critical requirement to pro-
duce a catalytically competent PKCa [15,16]. However,
although inactive on exogenous protein targets, PKCa un-
phosphorylated at Thr538 has been found to be able to under-
go autophosphorylation at Ser676, a residue localised in the
turn motif of the C-terminal region [16]. Here, we demon-
strate that the phosphorylation state of Thr538 plays a crucial
role in the control of both PKCa catalytic properties and
intracellular localisation.
2. Materials and methods
2.1. Cell culture and transfections
C44 MEL cells were obtained and cultured as speci¢ed previously
[17]. Total RNA was obtained from MEL cells and reverse transcrip-
tase-polymerase chain reaction was carried out as described [8]. The
primers used to construct a pEF1/V5-His B (Invitrogen) expression
vector, encoding PKCa cloned in the NotI/XbaI sites, were based on
the cDNA sequence of mouse PKCa (GI 6679352). They were: sense
5P-AATGCGGCCGCATGGCACCGTTTCTTCG-3P ; antisense 5P-
AATTTCTAGACAGGAGCAAATGAGAGTC-3P. Cell transfec-
tions were carried out using 2U106 cells, 4 Wg DNA and 8 Wl
DMRIE-C (Invitrogen) following the manufacturer’s instructions. Re-
combinant PKCa was immunoprecipitated from transiently trans-
fected cells using an anti-V5 antibody (Invitrogen) and the procedure
described previously [11]. T538CA and T538CE PKCa mutants were
generated using the QuickChange XL Site-Directed Mutagenesis kit
from Stratagene, and were completely sequenced.
2.2. Confocal microscopy
Cells were ¢xed, permeabilised and stained in the conditions speci-
¢ed previously [11]. The antibody dilutions were: 1:50 for monoclonal
PKCa N-terminal antibody raised against the 10^214 amino acid res-
idue fragment of human PKCa (Transduction Laboratories), 1:100
for PKCa C-terminal antibody (Santa Cruz Biotechnology); 1:200
for V5 antibody (Invitrogen). Secondary antibodies were: anti-mouse
Ig Alexa Fluor 488 conjugate (Molecular Probes), 1:300 dilution;
anti-mouse Ig (H+L) Texas red conjugate (Calbiochem), 1:100 dilu-
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tion; anti-rabbit Ig Alexa 488. Chromatin was stained by incubating
¢xed cells with 2 Wg/ml propidium iodide (Sigma Aldrich) for 5 min.
Wheat germ agglutinin (WGA) Alexa Fluor 488 conjugate (2 Wg/ml)
was used to visualise the Golgi complex.
2.3. Immunoprecipitation and assay of PKCa activity
Cells were lysed and PKCa was immunoprecipitated from 5U106
C44 MEL cells [11], using 2 Wg of the PKCa antibody speci¢ed else-
where. Immunoprecipitates were suspended in 30 Wl of 20 mM Tris,
pH 7.4, 0.14 M NaCl, 2.5 mM EDTA, 2.5 mM EGTA, 15 mM
MgCl2, 1 mM sodium orthovanadate, 5 mM dithiothreitol, 1 WM
ATP (Sigma Aldrich), 20 WCi [Q-32P]ATP (Amersham Biosciences),
and, where indicated, 3 ng phorbol myristate acetate (PMA; Sigma
Aldrich) and 5 Wg myelin basic protein (MBP; Sigma Aldrich). Re-
actions were carried out at 30‡C and, at the times speci¢ed elsewhere,
were stopped by adding sodium dodecyl sulfate^polyacrylamide gel
electrophoresis (SDS^PAGE) sample bu¡er and immediately heated
at 100‡C for 2 min. Where indicated, 2 WM PKCa pseudosubstrate
peptide (PP; Sigma Aldrich) was used as a PKCa inhibitor.
2.4. Western blotting
Total cell samples, cell fractions or immunoprecipitates were sub-
jected to SDS^PAGE (8% gel) and proteins were then transferred to
nitrocellulose membranes (Bio-Rad) as speci¢ed previously [11].
Blocked membranes were incubated for 1 h with one of the following
PKCa antibodies: C-terminal 1:1000 dilution; monoclonal N-termi-
nal 1:250 dilution; pThr538 1:1000 dilution (Cell Signaling Technol-
ogy); pSer676 1:1000 dilution, gift from Dr S. Shaw and Dr Y. Liu
[16]. V5 antibody was used at 1:5000 dilution. Immunoreactivities
were revealed with peroxidase-conjugated secondary antibodies (Santa
Cruz Biotechnology) developed with an enhanced chemiluminescence
detection system (Amersham Biosciences) [11]. Quanti¢cation of im-
munoreactive bands was carried out with a dual-wavelength £ying-
spot scanner (Shimadzu Corporation).
2.5. Cell fractionation
Isolation of detergent-soluble and detergent-insoluble fractions was
carried out as described [12] using 2U107 C44 MEL cells with the
following modi¢cations: cell lysing bu¡er contained 1% phosphatase
inhibitor cocktail II (Sigma Aldrich) and 1% Nonidet P-40. After
centrifugation at 200 000Ug for 15 min at 4‡C, the supernatant (de-
tergent-soluble material) and the pellet (detergent-insoluble material)
were collected, diluted in SDS^PAGE sample bu¡er and immediately
heated at 100‡C for 2 min.
3. Results
3.1. Identi¢cation of PKCa species
In whole MEL cell lysates we identi¢ed two di¡erently im-
munoreactive forms of PKCa, using antibodies directed to-
wards N-terminal and C-terminal regions of the kinase. As
shown in Fig. 1A, both antibodies recognised a 76 kDa pro-
tein band, named a-76, but the C-terminal antibody also de-
tected an 85 kDa protein band, named a-85. This immunore-
activity was eliminated by preincubation of the primary
antibody with the immunising peptide, thus con¢rming the
speci¢city of the isozyme immunorecognition. We examined
the distribution of a-76 and a-85 in two cell fractions, consist-
ing of detergent-soluble (cytosolic plus membrane fraction)
and detergent-insoluble material. As shown in Fig. 1B, a-76
was localised in the detergent-soluble material, whereas a-85
was associated with the detergent-insoluble material. It has
been shown that phosphorylation of PKC isozymes reduces
their electrophoretic migration in SDS^PAGE [18]. To deter-
mine whether a-76 and a-85 are characterised by di¡erent
phosphorylation patterns, we analysed their reactivity against
two phosphopeptide antibodies directed towards pSer676, a
C-terminal autophosphorylation site, and towards pThr538, a
transphosphorylation site localised in the kinase activation
loop. As shown in Fig. 1C, although both a-76 and a-85
proved to be phosphorylated at Ser676, only a-76 was phos-
phorylated at Thr538. Thus, unstimulated MEL cells contain
distinct forms of PKCa, distinguishable on the basis of their
phosphorylation pattern and intracellular localisation.
3.2. In vitro conversion of a-76 to a-85 species
To determine whether a-85, the slow-migrating PKCa spe-
cies in SDS^PAGE, can be produced by autophosphorylation
of a-76, the latter kinase form was immunoprecipitated from
MEL cells using the PKCa N-terminal antibody, which pref-
erentially recognises a-76 (see Fig. 1). Western blot analysis
carried out with the PKCa C-terminal antibody, which recog-
nises both a-76 and a-85 species, revealed that the immuno-
precipitated kinase consisted of a single immunoreactive band
with an Mr of 76 kDa (Fig. 2A). Autophosphorylation of the
isolated a-76 form was then induced by adding PMA, as an
activating lipid cofactor, in the presence of [Q32P]ATP. After
5 min autophosphorylation, an additional immunoreactive
band with the electrophoretic mobility of a-85 was also de-
tectable. The production of a-85 was fully prevented by add-
ing a PKCa PP to the autophosphorylation mixture, con¢rm-
ing that the slow-migrating protein band was a true product
of PKCa autophosphorylation activity. We also analysed the
immunoreactivity of the two PKCa forms present at the end
of the autophosphorylation assay by using the PKCa N-ter-
minal antibody. As shown in Fig. 2A, this antibody displayed
a lower a⁄nity for a-85 than the C-terminal antibody did,
thus explaining the discrepancy in the reactivity of these anti-
bodies towards a-76 and a-85 reported in Fig. 1A. An auto-
radiography analysis was also carried out following the auto-
phosphorylation reaction. As shown in Fig. 2B, both the a-76
and a-85 bands contained 32P, indicating that autophosphor-
ylation of the a-76 species had not reached completion or,
alternatively, that speci¢c molecular constraints present in a
Fig. 1. Identi¢cation of PKCa forms in MEL cells. Western blots
were carried out with PKCa N-terminal antibody (N), C-terminal
(C) antibody or the speci¢ed phosphopeptide antibodies. A: 105 to-
tal cells. The reactivity of the C-terminal antibody preincubated
with an excess of immunising peptide (IP) is also shown. B,C: De-
tergent-soluble (DS) and detergent-insoluble (DI) fractions from 105
cells. The above results were reproduced twice.
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fraction of a-76 molecules prevented the autophosphorylation
steps required to produce their conversion to a-85. We ¢rst
analysed the extent of conversion of a-76 to a-85 at increasing
times of autophosphorylation. As shown in Fig. 3, the reac-
tion reached a steady state within 10 min, when approxi-
mately 60% of a-76 was converted to a-85. We excluded
that this lack of completion in the conversion of the two
forms was caused by inactivation of the kinase or consump-
tion of ATP, as the enzyme was fully active on an exogenous
substrate at any time of incubation. Furthermore, the kinetics
of a-76/a-85 conversion was not a¡ected by the presence of
MBP in the incubation mixture, suggesting the occurrence of
intramolecular autophosphorylation.
We then examined the phosphorylation state of Thr538 on
both a-76 and a-85 throughout the autophosphorylation re-
action. pThr538 was found to be stably con¢ned to the a-76
protein band, and any attempt to detect pThr538 on a-85, by
prolonging incubation times or adding phosphatase inhibitors,
was unsuccessful (data not shown). Thus, we concluded that
a-76 molecules phosphorylated at Thr538 are not able to
undergo conversion to a-85 by autophosphorylation.
3.3. In vivo phosphorylation of PKCa
To establish whether a-76 and a-85 are also subject to in-
terconversion in vivo, cells were stimulated with PMA, and
the detergent-soluble and detergent-insoluble cell fractions
were analysed, at increasing times, by Western blot with dif-
ferent PKCa antibodies. As shown in Fig. 4A, PMA induced
a two-fold increase in the amount of a-85 associated with the
detergent-insoluble cell material, suggesting that PMA-pro-
moted autophosphorylation of a-76 caused its conversion to
a-85, which associated with the detergent-insoluble cell moi-
ety. In this cell localisation, a-85 persisted up to 60 min stim-
ulation. However, a fraction of a-76 did not undergo conver-
sion and remained in the detergent-soluble fraction. To
determine whether, in these conditions, a-76 and a-85 undergo
changes in the phosphorylation state at Ser676 and Thr538
residues, the detergent-soluble and -insoluble fractions of un-
stimulated or PMA-stimulated MEL cells were subsequently
analysed by Western blot with di¡erent phosphopeptide anti-
bodies. As shown in Fig. 4B, pSer676 was detectable on both
a-76 and a-85 at any time. When probed with the pThr538
antibody, the same blot showed that the level of phosphory-
lation on a-76 in the detergent-soluble fraction remained al-
most constant throughout cell stimulation with PMA. In con-
trast, a-85 in the detergent-insoluble fraction underwent
phosphorylation at Thr538 following 15 min cell exposure to
PMA. The slow kinetics of this phosphorylation step suggests
that it is catalysed by a protein kinase which undergoes trans-
location and/or activation in these conditions.
Fig. 2. Autophosphorylation of a-76. a-76 was immunoprecipitated
from unstimulated MEL cells using PKCa N-terminal antibody and
subjected to autophosphorylation for 5 min in the absence or pres-
ence of 2 WM PKCa PP. A: Western blot of the autophosphoryla-
tion products evaluated with PKCa C-terminal (C) or N-terminal
(N) antibody. B: Autoradiogram of corresponding lanes in A. Simi-
lar results were obtained in two additional experiments.
Fig. 3. Time course of a-76/a-85 conversion. a-76 was immunopreci-
pitated as in Fig. 2 and its autophosphorylation was carried out in
the absence (closed symbols) or presence (open symbols) of MBP.
At the indicated times, the amounts of a-76 (triangles) and a-85
(circles) species were quanti¢ed by Western blot with PKCa C-ter-
minal antibody. Data are expressed as the meanTS.D. of three sep-
arate experiments. 32P incorporation in MBP was assayed as speci-
¢ed in Section 2 (dotted line).
Fig. 4. E¡ect of PMA on a-76 and a-85 cell distribution and phos-
phorylation. A,B: Cells were stimulated with 100 ng/ml PMA for
the indicated times, and detergent-soluble (DS) and detergent-insolu-
ble (DI) fractions were analysed for a-76 and a-85 localisation with
PKCa C-terminal (C) or N-terminal (N) antibody. Phosphorylation
at speci¢c sites was evaluated with the indicated phosphopeptide
antibodies. The numbers above lanes represent the intensity of the
immunoreactive band calculated by densitometric scanning and as-
suming the arbitrary value 1 for the band present at 0 time in the
detergent-soluble or the detergent-insoluble cell fraction, respec-
tively. nd=not detectable. Similar results were obtained in two ad-
ditional experiments.
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3.4. PKCa intracellular localisations
To ascertain whether PKCa recovered in the detergent-in-
soluble material is associated with speci¢c cytoskeletal struc-
tures, the localisation of the kinase was analysed by confocal
microscopy in unstimulated and PMA-stimulated cells. As
shown in Fig. 5A,B, a fraction of PKCa was detectable in
the perinuclear cell region of unstimulated cells. Cells exposed
to PMA showed a translocation of PKCa to the plasma mem-
brane (Fig. 5C), but, also in this condition, a fraction of
PKCa remained located on a discrete structure in the perinu-
clear region. Speci¢cally, we identi¢ed a co-localisation be-
tween perinuclear PKCa and Golgi structures (Fig. 5D^F).
To explore whether the intracellular localisation of PKCa is
controlled by the phosphorylation state of Thr538, we pro-
duced MEL cells expressing T538CA or T538CE PKCa mu-
tants. T538CA PKCa showed an Mr of 88 kDa in Western
blot (not shown) and an almost complete localisation in the
Golgi area (Fig. 6). Strikingly, the intracellular distribution of
this kinase mutant did not change in cells exposed to PMA. In
contrast, T538CE PKCa showed an Mr of 79 kDa in Western
blot (not shown), and a di¡use intracellular localisation
(Fig. 6). Brief cell stimulation with PMA produced transloca-
tion of the kinase to the plasma membrane. These ¢ndings
support the idea that a non-phosphorylatable residue, or a
residue that mimics stable phosphorylation at the 538 position
in the kinase activation loop, crucially modi¢es the ability of
PKCa to be localised in speci¢c cell compartments.
3.5. Catalytic activity of PKCa from MEL cells
The presence of a-85 species associated with the Golgi com-
plex, but devoid of pThr538, raised the question of their cata-
lytic activation. To determine whether a-76 and a-85 express
catalytic activity on exogenous protein targets, both PKCa
species were isolated by immunoprecipitation from the deter-
gent-soluble and detergent-insoluble fractions of MEL cells,
respectively. The catalytic activity was then assayed on MBP
as a substrate. As shown in Table 1, a-76 activity was depen-
dent on the presence of PMA in the assay mixture. In con-
trast, a-85 was active in the absence of any added lipid cofac-
tor, but inactive when PMA was added to the assay mixture.
Recombinant T538CA PKCa, also isolated by immunoprecip-
itation, displayed a catalytic behaviour similar to a-85. These
Fig. 5. Changes in intracellular distribution of PKCa in PMA-stimulated cells. Wild-type (A^C) or T538CA PKCa transfected MEL cells (D^
F) unstimulated (A,B,D^F), or stimulated for 5 min with PMA (C), were ¢xed and PKCa localisation was evaluated using C-terminal PKCa
antibody (A^C) (green £uorescence) or anti-V5 antibody (D) (red £uorescence). The confocal microscopy image in B was acquired by photon
counting mode. Chromatin was stained with propidium iodide (red £uorescence in A^C). WGA Alexa 488 was used to monitor the Golgi com-
plex (green £uorescence in E). F: Merged image of D and E. Images are representative of data obtained on analysing at least 30 cells in ran-
dom non-overlapping ¢elds. Arrows indicate Golgi-associated PKCa. Bar= 10 Wm.
Table 1
PKCa species Kinase activity (cpm)
3PMA +PMA 3PMA+PP
a-76 180T 50 1800T 200 110T35
a-85 1500T 200 310T 60 160T45
T538CA 1650T 180 200T 40 150T60
a-76 was immunoprecipitated from the detergent-soluble and a-85 from the detergent-insoluble material of C44 cells. T538CA PKCa was iso-
lated by immunoprecipitation with V5 antibody from cells 24 h after transfection. Aliquots of the immunoprecipitates were assayed for kinase
activity as speci¢ed in Section 2. After 5 min at 30‡C, reactions were stopped by adding SDS^PAGE sample bu¡er, and samples were immedi-
ately heated at 100‡C for 2 min.
After electrophoresis MBP bands were identi¢ed by autoradiography and then cut; 32P incorporation was measured in a Beckman LS6500 scin-
tillation counter. Values are the meanTS.D. of three separate experiments.
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observations indicate that PKCa species localised in the Golgi
region, although lacking pThr538, do not require exogenous
activating cofactors to express catalytic activity towards pro-
tein targets.
4. Discussion
In this study, we identi¢ed di¡erent PKCa species and an-
alysed their molecular and catalytic properties. We recovered
a PKCa species associated with the detergent-insoluble frac-
tion in both unstimulated and PMA-stimulated MEL cells.
This kinase is easily distinguishable from PKCas localised in
the detergent-soluble cell fraction, as it shows a gel shift from
an Mr of 76 to 85 kDa in SDS^PAGE. We demonstrated that
in vitro the 76 kDa PKCa (a-76) can be converted by auto-
phosphorylation to a new species with lower electrophoretic
mobility and an apparent molecular mass of 85 kDa (a-85).
With regard to autophosphorylation sites, Ser676 residue in the
turn motif of PKCa proved to be constitutively phosphory-
lated, as both a-76 and a-85 were recognised by a pSer676-
speci¢c antibody in unstimulated and PMA-stimulated cells.
Thus, we excluded that autophosphorylation at this site is
su⁄cient to promote the observed gel shift of a-76 to a-85.
The hydrophobic motif peptide, which is conserved among
PKC isozymes and has been proposed as a molecular switch
in the partitioning of PKCs between detergent-soluble and -
insoluble cell fractions [13], also proved to be constitutively
phosphorylated at Ser695 on both a-76 and a-85 in MEL cells
(M. Passalacqua, unpublished data). Although the phosphor-
ylation of this peptide could participate in regulating the af-
¢nity of the various PKC isozymes for specialised intracellular
docking sites in unstimulated MEL cells, the presence of
pSer695 also in a-76 suggests that a-76/a-85 conversion is not
due to PKCa autophosphorylation at this site. Putative nPKC
substrate sequence motifs, characterised by the presence of
basic residues between the 34 and 32 positions and a hydro-
phobic residue at the +1 position [19], are present at Ser370
and Ser433 in a region of PKCa stretching from the end of the
regulatory to the beginning of the catalytic domain. At
present, we can only speculate that these favourable sites of
autophosphorylation might participate in a-76/a-85 conver-
sion by a cis or trans catalytic mechanism which in any case
produces a species with reduced immunoreactivity to the
PKCa N-terminal antibody. Further experiments are neces-
sary to identify these autophosphorylation sites.
Treatment of a-85 with both alkaline phosphatase and pro-
tein phosphatase V was not su⁄cient to obtain its re-conver-
sion to a-76 (data not shown). This result suggests that auto-
phosphorylation of a-76 leads to a phosphatase-resistant
PKCa form. The presence of a molecular constraint, which
controls both accumulation of phosphate at other PKC sites
and phosphatase sensitivity, has also been described previ-
ously for the PKCK isozyme [20].
Interestingly, the a-76/a-85 protein conversion is restricted
to a-76 molecules not phosphorylated at Thr538. Hence,
although the detergent-soluble a-76 pool is composed of dif-
Fig. 6. Intracellular localisation of PKCa mutants. Cells expressing the indicated PKCa mutants were ¢xed 24 h after transfection and stained
with V5 antibody followed by an Alexa 488-conjugated secondary antibody. Left panels represent unstimulated cells, right panels represent
1 min PMA-stimulated cells. Bar= 10 Wm. The results are representative of data obtained on analysing at least 30 cells in random non-overlap-
ping ¢elds.
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ferent kinase species that contain Thr538 or pThr538 in the
kinase activation loop, only a-76 kinases not phosphorylated
at this site are able to catalyse the autophosphorylation steps
that result in the conversion to a-85. Surprisingly, also a-85
species found to be associated with the detergent-insoluble
fraction of unstimulated MEL cells do not contain any detect-
able pThr538. The relevance of the Thr538 phosphorylation
state in the intracellular distribution of PKCa is supported
by evidence obtained by using PKCa mutated at this amino
acid residue. Substitution of Thr538 with a non-phosphorylat-
able residue is su⁄cient to induce association of the kinase
with the Golgi complex; conversely, its substitution with a
residue that mimics pThr [16] promotes a preferential cell-
soluble localisation.
We have shown that Golgi-associated a-85 can be subse-
quently phosphorylated at Thr538 in cells stimulated with
PMA. PDK1 has been proposed as a potential kinase in-
volved in Thr538 phosphorylation [15], and a physical interac-
tion between PKCa and PDK1 has also been described [16].
In any case, the slow kinetics of Thr538 phosphorylation ob-
served in PMA-treated MEL cells suggests that the protein
kinase responsible for PKCa activation loop phosphorylation
either needs to be recruited to the detergent-insoluble com-
partment containing a-85, or requires an activation process to
recognise a-85 as a substrate.
Thr538 phosphorylation has been shown to be a critical
requirement for the catalytic competence of PKCa. In agree-
ment with previous observations [16], we found that T538CA
PKCa is inactive when assayed in the presence of PMA. How-
ever, surprisingly, both wild-type a-85 and T538CA PKCa
Golgi-associated species were able to phosphorylate an exog-
enous substrate in the absence of PMA. Previous reports also
described an inhibitory e¡ect of lipid molecules on di¡erent
PKC isozymes [21,22], but the molecular details of the inhi-
bition of PKCa species by PMA remain to be explored.
The presence of an active PKCa associated with the Golgi
complex can be ascribed to a co-immunoprecipitated activat-
ing cofactor. In mitotic cells the catalytic activation of a
PKCa species localised in centrosomes and kinetochores has
been shown to depend on the interaction of this kinase with a
protein cofactor [23]. To date, the activating cofactor of
PKCa species translocated to the Golgi complex in interphase
cells has not been identi¢ed. PKCO and N isozymes, which, like
PKCa, belong to the novel PKC subfamily, have been found
to be transiently translocated to the Golgi complex [24,25].
However, the constitutive localisation of PKCa species in
this cell region, as well as the absence of its further trans-
location to the plasma membrane by PMA, suggests that a
distinct molecular mechanism is involved in the process of
PKCa recruitment to the Golgi complex. This conclusion is
further supported by recent evidence of a constitutive local-
isation of the PKCa regulatory domain in the Golgi complex
in Jurkat cells [26]. Divergent primary structures, shown spe-
ci¢cally in the regulatory domains of the homologous PKCN
and a isozymes, may be responsible for their di¡erent inter-
action with Golgi structures.
Studies are in progress to explore this hypothesis and to
de¢ne the functional role of the di¡erent PKCa species in
MEL cells.
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